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The bacitracin biosynthesis operon of Bacillus licheniformis 
ATCC 10716: molecular characterization of three multi-modular 
peptide synthetases 
Dirk Konzl, Andrea Klensl, Kurt Schbrgendorfer* and Mohamed A Marahiell 
Background: The branched cyclic dodecylpeptide antibiotic bacitracin, 
produced by special strains of Bacillus, is synthesized nonribosomally by a 
large multienzyme complex composed of the three bacitracin synthetases BAl , 
BA2 and BA3. These enzymes activate and incorporate the constituent amino 
acids of bacitracin by a thiotemplate mechanism in a pathway driven by a 
protein template. The biochemical features of these enzymes have been studied 
intensively but little is known about the molecular organization of their genes. 
Results: The entire bacitracin synthetase operon containing the genes 
bacA-bacC was cloned and sequenced, identifying a modular structure typical 
of peptide synthetases. The bacA gene product (BAI , 598 kDa) contains five 
modules, with an internal epimerization domain attached to the fourth; bacB 
encodes BA2 (297 kDa), and has two modules and a carboxy-terminal 
epimerization domain; bacC encodes BA3, five modules (723 kDa) with 
additional internal epimerization domains attached to the second and fourth. A 
carboxy-terminal putative thioesterase domain was also detected in BA3. A 
putative cyclization domain was found in BAl that may be involved in thiazoline 
ring formation. The adenylation/thioester-binding domains of the first two BAl 
modules were overproduced and the detected amino-acid specificity coincides 
with the first two amino acids in bacitracin. Disruption of chromosomal bacB 
resulted in a bacitracin-deficient mutant. 
Conclusions: The genes encoding the bacitracin synthetases BAl , BA2 and 
BA3 are organized in an operon, the structure of which reflects the modular 
architecture expected of peptide synthetases. In addition, a putative thiazoline 
ring formation domain was identified in the BAl gene. 
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Introduction 
Bacitracins are antibiotic polypeptides produced by 
certain strains of Bacillus lic/leniformis [1,2] and Bacillus 
suMis [3]. Crudely purified bacitracin contains at least 10 
distinct dodecapeptides that differ by one or two amino 
acids [4]. The most abundant and best characterized of 
these peptides is bacitracin A (Figure la), a branched 
cyclic dodecapeptide. It contains an amino-terminal 
linear pentapeptide moiety with an isoleucine-cysteine 
thiazoline condensation product and a carboxy-terminal 
heptapeptide ring, in which the free a-carboxy group of 
the carboxy-terminal Asn is bound to the E-amino group 
of lysine. As well as proteinogenic amino acids, four 
amino acids in the D-configuration (Glu4,Orn7, Phe9 and 
Aspll) and the nonproteinogenic residue ornithine (Orn) 
are incorporated into bacitracin A. Bacitracin A is most 
active against Gram-positive bacteria and acts by inhibit- 
ing bacterial cell-wall biosynthesis: bacitracin A forms a 
tight ternary complex with C,,-isoprenyl pyrophosphate 
(IPP) and a divalent metal cation [5,6]. IPP serves as a 
membrane-associated carrier during the synthesis of the 
repeat subunits of peptidoglycan. Recycling of IPP 
involves its dephosphorylation to C,,-isoprenyl phos- 
phate (IP) by a phosphatase at the end of each cycle; this 
step is blocked by the bacitracin-MZ+-IPP-complex 
(where M2+ is a divalent metal ion), resulting in an accu- 
mulation of uridine diphosphate-acetylmuramyl pen- 
tapeptide. This model for bacitracin action is supported 
by recently described mechanisms for bacitracin resis- 
tance involving the production of increased IPP [7,8]. 
Besides this primary mode of action, bacitracin also 
seems to affect membrane functions [9], the action of 
certain hydrolytic enzymes [lo], and the biosynthesis of 
ubiquinone precursors [ 111. 
Like many other peptide antibiotics from Bacdus [12], 
bacitracin is produced nonribosomally by a large multi- 
enzyme complex [13-151 utilizing a thiotemplate mecha- 
nism [16-201. In this mechanism, large multifunctional 
enzymes, designated peptide synthetases, activate their 
substrate amino acids as aminoacyl adenylates using ATP 
hydrolysis. These unstable intermediates are subsequently 
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(a) Primary structure of bacitracin A. Brackets embrace the residues domain organization of the peptide synthetases is illustrated within the 
incorporated by the three bacitracin synthetases BAl , BA2 and BA3. genes. (d) PCR fragment 05 used for the screening of the h-EMBL3 
The thiazoline ring, a product of isoleucine and cysteine cyclization, is genomic library and h clones isolated in this work. Probes A and B used 
highlighted in yellow. (b) The color code of the patterns used for for chromosomal walking are marked in light blue. (e) Gene fragments, 
different domains in the remainder of the figure. (c) Physical corresponding to AT domains, were overexpressed and biochemically 
organization of the bat operon. Three genes, bacA, 6acB and bacC analyzed. Plasmid pBAC-BA was used for the construction of a bacB 
coding for the bacitracin synthetases BAl -BA3 were identified. The gene disruption mutant. Abreviations: Orn, ornithine; E, EcoRl; S, WT. 
transferred to a covalently enzyme-bound 4’-phospho- 
pantetheinyl (4’-PP)-cofactor as thioesters. The peptide 
product is generated by the stepwise incorporation of the 
thioesterified amino acids in a series of amino- to carboxy- 
terminal-directed transpeptidations. Thorough sequence 
analysis of several genes encoding peptide synthetases has 
unveiled a modular organization principle for this class of 
enzymes [l&21-231. The detected modules (around 1000 
amino acids each) are responsible for the activation and 
incorporation of a single amino acid and thus are arranged 
in a colinear fashion with the product peptide [B-26]. If a 
biosynthetic complex consists of several peptide syn- 
thetases, the colinearity of the modules is conserved 
within each single enzyme [17,18]. Each module can be 
subdivided into several specific domains [20,22,27]. The 
adenylation (A) domain (550 amino acids) is the elemen- 
tary domain of each module and catalyzes the specific acti- 
vation of a given substrate amino acid. This module 
belongs to the large family of adenylate-forming enzymes 
that includes firefly luciferase [28] and the acetyl-CoA syn- 
thetases [ZZ]. The adjacent thioester-binding (T) domain 
(80 amino acids) shares high homology with the acyl carrier 
protein (ACP) that is involved in fatty acid and polyketide 
synthesis. It contains the highly conserved sequence motif 
LGGxJ’I (using single-letter amino-acid code, with x as 
any amino acid) with an invariant serine residue (itali- 
cized), which is the 4’-PP-attachment site [29-311. In con- 
trast to the original model of the thiotemplate mechanism, 
which suggested that a single 4’-PP-cofactor would act as a 
‘swinging arm’ to transfer the growing peptide chain from 
one module to the next, the presence of such a cofactor at 
each module of a multimodular PPS has recently been 
shown [32]; this finding established the ‘multiple carrier 
model’ for nonribosomal peptide synthesis. The T domain 
is followed by a recently reported condensation (C) 
domain (3.50 amino acids), which is thought to catalyze 
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peptide bond formation [33]. Within peptide synthetases 
with a single polypeptide chain, the C domain is always 
found between two A domains. If the peptide biosynthesis 
complex is composed of several peptide synthetases, the 
subunit that activates the first amino acid of the peptide 
lacks a C domain. The C domain is found instead at the 
amino-terminal end of subunits that catalyze activation 
and transfer of the distal amino acids of the peptide. In 
modules that catalyze the incorporation of N-methylated 
amino acids, an additional N-methylase domain (350 amino 
acids) is inserted between the A and T domains [24,25]. If 
the module introduces D-amino acids, the T domain is fol- 
lowed by an epimerization (E) domain (400 amino acids) 
[27,34]. In many bacterial systems the module that cat- 
alyzes the incorporation of the carboxy-terminal amino 
acid of the product peptide contains an additional putative 
thioesterase (Te) domain; Te domains are thought to play 
a role in peptide chain release or cyclization [ZO]. 
The biochemical pathway of bacitracin production has 
been studied intensively and the enzymes involved in 
bacitracin’s biosynthesis were identified and characterized 
20 years ago [13-151. Bacitracin is synthesized by a large 
multienzyme complex, composed of three peptide syn- 
thetases BAl, BA2 and BA3. BAl activates the five amino 
acids contained in the linear portion of the peptide; BA2 
and BA3 activate the remaining amino acids of the hep- 
tapeptide ring (Figure la). In contrast to the mass of bio- 
chemical data, little is known about the bacitracin 
synthetase genes. Recently, the cloning and expression of 
the bacB and (partial) bad genes (both are located on a 
32 kb fragment of B. l&enifom2is) and expression of these 
genes in Eschetichia coli has been reported [35], indicating 
that the genes for bacitracin synthesis are clustered in the 
genome of B. lict5enifomnis. This proposition was supported 
by the isolation of a Tn917-generated bacitracin-deficient 
mutant with an insertion in the vicinity of the bacB gene 
[36], but to date the sequences of the genes have not been 
available. Given that the bacitracin-biosynthesis system is 
one of the best biochemically characterized systems for 
nonribosomal peptide synthesis, analysis of bacitracin syn- 
thetase gene sequences is of great importance. Of particu- 
lar note is the fact that BAl and BA3, on the basis of 
biochemical data, incorporate three D-amino aci’ds 
(D-Glu4, D-Phe9 and D-Aspll) from putative internal 
modules, which are expected to lead to the generation of 
of internal E domains. In all reported prokaryotic genes of 
peptide synthetases to date, E domains are located exclu- 
sively at the carboxy-terminal end of the enzyme [27]. 
Thus, detailed sequence information could lead to new 
insights into the general architecture of peptide syn- 
thetases. Furthermore, the analysis of the bacA gene is a 
subject of outstanding interest from another point of 
view - chemical investigations of the isoleucylcysteine 
intermediate isolated from BAl preparations have indi- 
cated that the thiazoline ring is formed at the dipeptide 
stage [37], so an unusual organization of the first two BAl 
modules is to be expected. 
In this study we report the cloning and sequencing of the 
entire bat operon from B. l&enzj&nis. Three genes, bacA, 
bacB and bad‘, coding for the three biochemically identified 
bacitracin synthetases were sequenced. The genes reflect 
the typical structure of a peptide synthetase, with five 
modules in bacA, two in bacB and five in bad’. The chromo- 
somal arrangement of the genes is in the same order as their 
biochemical action. Complete sequence analysis of bacA 
and bacC revealed that they contain modules with internal 
E domains, the first example of these domains in prokary- 
otic peptide synthetases. In addition, a strongly modified C 
domain was identified between the first two A domains of 
bacA; this region shares highest homologies with proteins 
involved in the nonribosomal synthesis of thiazoline-con- 
taining siderophores (iron-chelating compounds) [38-411. 
We conclude that this region represents a new kind of 
domain in peptide synthetases, and that it catalyzes the for- 
mation of a thiazoline ring. The deduced amino acid speci- 
ficity of the first two BAl modules was confirmed by 
cloning, heterologous expression in E. coli and ATP-PP, 
exchange assays with purified domain proteins. Further- 
more, the relevance of the cloned genes in bacitracin 
biosynthesis was demonstrated by constructing a bacitracin- 
deficient bacB gene-disruption mutant. 
Results and discussion 
Cloning and sequencing of the bat opeton 
We used a recently reported method based on the poly- 
merase chain reaction (PCR) for the identification of 
peptide synthetase genes [42]. Using degenerate oligonu- 
cleotide primers derived from the core sequences 4 
(Thr-Glu-Asp) and 6 (Leu-Glu-Glu-x-Ser-Be) of 
peptide synthetases [27] a DNA fragment, designated 
PCROS, was PCR-amplified from the chromosome of 
B. lichenijhnis ATCC 10716. Sequencing this fragment 
identified the internal core sequence 5 (KIRGxRIEL- 
GEIE; using the single-letter amino-acid code, with x as 
any amino acid) and another highly conserved sequence 
motif (NGK), both of which are characteristic of peptide 
synthetases, thus indicating that PCROS represents a part 
of a peptide synthetase gene. In order to clone the com- 
plete peptide synthetase gene, we constructed a X-EMBL3 
genomic library of B. hchenifonnis ATCC 10716 and 
screened this library using the PCROS fragment as probe. 
Seven h clones that hybridized with the probe were iso- 
lated. One of them, designated k-BAl (Figure Id) was 
further investigated. The 19.5 kilobase (kb) insert of 
k-BAl was mapped and subcloned into pBluescript SK(-) 
using the restriction enzymes EcoRI and SaA. By terminal 
sequencing of the resulting subclones, it was shown that 
the h-BAl DNA insert shares homology with peptide syn- 
thetase genes over the entire stretch of 19.5 kb. To iden- 
tify the remaining part of the peptide synthetase gene, an 
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additional step of chromosomal walking was performed; .5’- 
(probe A) and 3’-(probe B) terminal restriction fragments of 
the h-BAl insert were used to screen the A-EMBLS 
genomic library (Figure Id). Fourteen phages that reacted 
with probe A and 17 that hybridized with probe B were iso- 
lated. The inserts of the isolated phages were mapped and 
analyzed by Southern blot experiments. One clone of each 
set, which showed only short overlaps with h-BAl, named 
h-A14.3 (18 kb insert) and h-B132 (16 kb insert; see 
Figure Id), were subcloned into pBluescript SK(-) using 
EcoRI and SalI. Terminal sequencing of these subclones 
showed that each phage contained one terminal region 
lacking homology to peptide synthetase genes, indicating 
that the complete peptide synthetase gene had been 
cloned. Altogether, the three h-phages BAl, A14.3 and 
B13.2 span a continuous region of 46 kb. The entire 
nucleotide sequences of the subclones were determined, 
and remaining gaps between the subclones were filled by 
PCR amplification from chromosomal DNA. In all, 
43,297 base pairs (bp) of B. lichenifomzis were sequenced, 
and the sequences had a typical GC-content of about 46%. 
The bat operon consists of the three genes, bacA, bad 
and bacC, coding for the bacitracin synthetases BAl, BA2 
and BA3 
Analysis of the subcloned nucleotide sequence revealed 
three huge open reading frames (ORFs) with the same 
direction of transcription. The first ORF, designated bacA, 
is 15,768 bp in length and codes for a protein of 
5,255 amino acids and a predicted mass of 598,379Da. By 
detailed alignments with the deduced amino-acid 
sequence, five modules typical of peptide synthetases 
were identified. Each of these modules consists of an A 
domain and a T domain. The first module lacks an amino- 
terminal C domain, suggesting that it might be the initia- 
tion module [33]. A strongly modified C domain, 
designated as a putative cyclization (Cy) domain, was 
identified between the first two A domains (described in 
detail below). The remaining A domains are connected by 
homologous and classical C domains. Module 4 carries an 
additional E domain inserted between its T and the fol- 
lowing C domain. This organization resembles the 
arrangement of domains found in the first module of HC- 
toxin synthetase Htsl [26], which is responsible for the 
incorporation of D-proline in the modified tetrapeptide 
HC-toxin. Taken together, these findings are in perfect 
agreement with the requirements for BAl activity: induc- 
tion of peptide synthesis; activation and incorporation of 
five amino acids; thiazoline ring formation between the 
first two amino acids and incorporation of a D-amino acid 
(D-glutamine) in the fourth position. 
The second identified ORF, of 7,824 bp, is named bacB, 
and codes for a protein of 2,607 amino acids with a calcu- 
lated mass of 297,428Da. The derived amino acid 
sequence is composed of two AT domains, each coupled 
with an amino-terminal C domain. Furthermore a carboxy- 
terminal E domain was found, indicating that this protein 
might be BA2, which activates two amino acids and incor- 
porates a D-amino acid (ornithine) from its second active 
site into bacitracin. ORF 3, designated bacC, spans a 
stretch of 19,080 bp, coding for a giant protein of 
6,359 amino acids with a predicted mass of 722,943Da. 
This protein consists of five modules each made up of 
C-A-T domains (see Figure 1). The second and fourth 
modules additionally bear an internal E domain inserted 
in the same fashion as described for module 4 of bacA. A 
putative thioesterase domain was found attached to the 
carboxy-terminal module. This organization of domains 
corresponds fully with the biochemical properties of BA3: 
activation of five amino acids; incorporation of two D- 
amino acids catalyzed by its second and forth active sites 
and release and cyclization of mature bacitracin. Taken 
together, the three genes bacA, bacB and bad span a 
stretch of 42,886 bp. There are several putative start 
codons for bacB; but the ATG at bp 16,191, which is 
located 112 bp downstream of the bacA stop codon, seems 
to be the most probable. The bacB and bad genes are sep- 
arated by 105 bp. In other bacterial systems such as grami- 
cidin S [43], surfactin [21] and tyrocidine [23,44] the genes 
encoding for the peptide synthetases were shown to be 
organized in operons. As judged by the short distance 
between the identified genes and the absence of any 
detectable termination signals we propose that bacA, bacB 
and bacC comprise an operon. 
Analysis of the primary structure of the bacitracin peptide 
synthetase reveals a highly ordered domain structure that 
obeys the empirical rules for the molecular architecture of 
peptide synthetases that have been elaborated in recent 
years following the sequencing of several such genes 
[17,20,30]. In particular, the first examples of internal E 
domains in bacterial peptide synthetase systems, reported 
here, underline once more the idea that peptide syn- 
thetases can be understood as chains of several linear 
coupled domains that catalyze specific reactions according 
to their positions within these chains. 
Homology of BAl to proteins involved in the nonribosomal 
synthesis of siderophores 
One of the most striking structural features of the polypep- 
tide antibiotic bacitracin is the thiazoline ring formed 
between the first two amino-terminal amino acids 
(isoleucine-cysteine). Biochemical studies of the bacitracin 
synthetases have revealed that the heterocycle formation is 
catalyzed by BAl at the dipeptide stage [37]. We character- 
ized the bacA gene encoding BAl at the molecular level and 
identified an unusual domain between the first two modules 
of this enzyme. A search of the GenBank database was per- 
formed with the BLASTX program to determine if this 
domain had significant homology with known protein 
sequences [45]. The highest percentage of similarity was 
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Table 1 
Homology of putative cyclization domains. 
HMWPP-1 HMWP2-2 MTCY22H8.02 AngR 
BAl :l-2 44% 51% 48% 360/o 
HMWPS-1 50% 51% 43% 
HMWP2-2 48% 374/o 
MTCY22H8.02 35% 
AngR 
Percentage of homology found for the putative cyclization domains of 
BAl, HMWPP, MTCY22H8.02 and AngR when aligned with the 
clustalw program. 
which are thought to play a key role in the transpeptidation 
catalysis [33], are missing from Cy domains, although the 
aspartic acid and serine residues are strongly conserved in 
both types of domain. These data, in combination with the 
fact that no additional sequence other than the identified 
Cy domain is located between the first two modules of 
BAl, led us to the suggestion that the identified Cy 
domain catalyzes both peptide bond formation and thiazo- 
line ring formation. Thus, analysis of the conserved 
residues in C and Cy domains, by site-directed mutagene- 
sis, could provide a deeper insight into the molecular 
mechanisms of transpeptidation catalysis by peptide syn- 
thetases. An enzyme complex involved in the post-transla- 
tional formation of thiazole and oxazole rings in the 
ribosomally synthesized polypeptide antibiotic microcin 
B17 of E. coli has recently been reported [50]. This 
complex, composed of the three enzymes McbB-McbD, 
introduces four thiazole and four oxazole rings into premi- 
crocin B17 involving the sidechains of serine and cysteine 
residues. In a sequence alignment of McbB-McbD with 
the Cy domains identified in this report, no significant 
homologies were detected. These data indicate that both 
systems catalyze similar reactions but utilize alternative 
mechanisms of heterocycle formation. 
found with a group of three proteins: HMWPZ of Yeninia 
enterocolitica, MTCY22H8.02 of Mycobacten’um tuberculosis 
and AngR of Vibrio angzillamum (Table 1) [38,39,41]. 
HMWPZ and AngR are reported to be involved in the nonri- 
bosomal synthesis of the thiazoline-containing siderophores 
yersiniabactin (HMWPZ) and anguibactin (AngR), respec- 
tively [38,46]. The biological function of MTCY22H8.02 is 
not known, but the gene encoding it is located in a gene 
cluster with an aryl-AMP-ligase (MTCY22H8.01), polyke- 
tide synthetase analogues (MTCYZ2H8.03/04) and a 
peptide synthetase (MTCY22H8.05) [41]. It is possible that 
MTCY22H8.02 might also be involved in the nonribosomal 
synthesis of a heterocycle-containing catechol siderophore 
like yersiniabactin, anguibactin or pyochelin of Pseudomonas 
aeruginosa (Figure 2a) [47-49]. The comparative sequence 
analysis of BAl, HMWPZ, MTCY22H8.02 and AngR 
revealed that our proteins have a similar domain structure. 
Each sequence harbors a core module containing an unusual 
domain comparable to the one identified in BAl plus an A 
and T domain. In HMWP2, an additional domain of 
unknown function is inserted between the A and T 
domains. At the amino-terminal side of such modules, a T 
domain is detected in BAl, HMWPZ and MTCY22H8.02. 
Another Cy domain is found at the carboxyl terminus of 
HMWPZ, and a putative Te domain is found at the carboxyl 
terminus of MTCY22H8.02 (Figure 2b). Taken together 
these findings indicate that the four enzymes catalyze 
similar reactions and that the newly identified type of 
domain might be involved in the catalysis of thiazoline ring 
formation, so we have designated this domain as a putative 
cyclization (Cy) domain. 
By aligning the five homologous Cy domains, seven con- 
served regions Cyl-7 (Figure 2c) were identified. When 
the Cy domain was compared with C domains of peptide 
synthetases (25-33% homology), some residues were iden- 
tified that are conserved in both types of domains 
(Figure 2b) whereas others are unique to each domain. The 
most noticeable difference between the two types is the 
reduced conservation of the HHIxDGS signature-sequence 
motif in Cy domains. In particular, the histidine residues, 
Amplification, expression and biochemical characterization 
of the first two BAl AT domains 
DNA fragments corresponding to the AT domains of the 
first two BAl-modules were amplified by PCR out of total 
DNA from B. lichenifonnis ATCC 10716. The first module 
fragment baacAl-AT (1,946 bp) was amplified with the 
native amino terminus of BAl and the carboxy-terminal 
end was chosen 75 residues downstream of the core 
sequence 6 (MGGxS) [18]. For the second module 
bacA2-AT (1,856 bp) an amino-terminal primer located 98 
residues in front of core sequence 1 (LKtGA) and a 
carboxy-terminal primer 6.5 residues behind core 
sequence 6 (IGGDS) were used [18,23]. The DNA frag- 
ments obtained were cloned into the pQE expression 
vector as described in Materials and methods. Expression 
in E. coli yielded H&tagged recombinant domain pro- 
teins, designated BacAl-AT and BacA2-AT, which were 
found to be completely soluble (Figure 3). The observed 
electrophoretic mobility on SDS-PAGE was in good agree- 
ment with the calculated mass of 73,164 Da for BacAl-AT 
and 70,461 Da for BacA2-AT. Purification of these pro- 
teins was performed by Niz+-chelate affinity chromatogra- 
phy. The resulting protein fractions were applied to amino 
acid-dependent ATP-PP, exchange assays using all 20 pro- 
teinogenic amino acids plus ornithine and one control 
without amino acids. The results of these experiments are 
presented in Figure 4, and clearly reveal that BacAl-AT 
specifically activates isoleucine, whereas BacA2-AT acti- 
vates cysteine. If the highest activation for each domain 
protein is defined as lOO%, the measured background level 
of the control reaction without amino acids was found to be 
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Figure 2 
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(a) Primary structures of the nonribosomally 
produced siderophores anguibactin [47], 
yersiniabactin [481 and pyochelin, with their 
possible synthetic proteins in parentheses 
(where known) [491. (b) Comparative 
alignment of BAl :l-2, HMWPS, 
MTCY22H8.02 and AngR. The colored 
regions indicate the identified domains: green, 
thioester-binding (T) domain; yellow, putative- 
cyclization (Cy) domain; red, adenylation (A) 
domain; grey, not identified; light purple, 
thioesterase (Te) domain. Dark lines in the 
different domains indicate the position of 
highly conserved sequence motifs [271. 
(c) Alignments of amino-acid sequences of the 
cyclization (Cy) putative domains of BAl :l -2 
(residues 621-l 038) of B. licheniformis with 
HMWPP-1 (residues l OO-512), HMWP2-2 
(residues 1481-l 885) of K enferocolitica 
1381, MTCY22H8.02 (residues 85-492) of M. 
tuberculosis [41 I and AngR (residues l-398) 
of V. anguillarum 1391 performed with the 
clustalw program. Identical amino acids and 
amino acids that match four of the five 
templates are indicated by yellow shading. The 
boxed sequences represent the seven highly 
conserved signature sequences (Cl -C7). 
Residues that are also conserved in C 
domains are marked by stars above the 
sequence. 
< l%.for both samples. With BacAl-AT, a small side pref- was identified. The specific activation of isoleucine and 
erence for leucine (4.5%), phenylalanine (4%) and valine cysteine strongly supports the statement that bacA encodes 
(3%) was detected, whereas the activities for the remaining for the bacitracin synthetase BAl and it can be assumed 
amino acids were in the same range as background. In the that bacB and bacC represent the structural genes encoding 
assay with BacAZ-AT, no comparable alternative activation BA2 and BA3. 
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Figure 3 
The first two BAl AT domains. Coomassie 
Brilliant Blue stained SDS-polyacrylamide 
gels of f. co/i overexpressed AT domains 
(a) BacAl -AT and (b) BacA2-AT. Lane 1, 
whole cell extract before induction; lane 2, 
whole cell extract after 2 h induction with 
IPTG; lane 3, pellet; lane 4, supernatant after 
lysis; lane 5 purified protein. 
, (4 W 
kDa MW 1 2 3 4 5 kDa MW 1 2 3 4 5 
;: z - 
60 - 
50 - 
Chemistry 8 Biology 
Disruption of the bad3 gene 
A bacB gene-disruption mutant was constructed in order 
to confirm the role of the bat gene products in the biosyn- 
thesis of bacitracin. A special strategy for genetic modifi- 
cation in B. l~c&$&-mis had to be performed, because B. 
lz&nifomzis lacks natural competence, and the cells are 
also unable to perform of integrative recombination when 
transformed through the protoplast method. We therefore 
constructed the integrative plasmid pBAC-BD which 
bears a temperature-sensitive origin of replication 
(REPts) [Sl] and an internal fragment of the bacB gene 
with an inserted kanamycin-resistance cassette (Figure 5) 
[SZ]. This plasmid was transformed into B. hieniformis 
protoplasts at a permissive temperature below 32°C and 
kanamycin-resistant (Kan’) colonies were isolated. A heat- 
shock treatment (48°C) of these colonies in the presence 
of kanamycin was performed in order to inactivate REPts 
and to force an integrative recombination event. Ten 
Kanr resistant colonies were obtained which, when 
Figure 4 
Results of amino acid-dependent ATP-PP, 
exchange experiments with the purified AT 
domains BacAl -AT and BacA2-AT. Assays 
were performed with all 20 proteinogenic 
amino acids plus ornithine and one control 
without amino acids. 
applied to a microbiological growth-inhibition test with 
Micrococcus flavus, showed no bacitracin production. One 
of these colonies, designated B. lichniformis AKl, was 
further investigated. Southern blot analysis using the 
kanamycin-resistance cassette and the internal bacB frag- 
ment BAC-BE (Figure 5) as probes demonstrated that 
the resistance cassette had integrated into the chromoso- 
ma1 bacB gene by a double-crossover recombination 
event (data not shown). To confirm the results of the 
microbiological assay culture, broth from B. lkheniformis 
strains ATCC 10716 and AK1 was extracted with butanol, 
and analyzed by high performance liquid chromatography 
(HPLC; Figure 6). A prominent elution peak at 95 min 
was detected for the wild-type extract but was com- 
pletely absent from the AK1 extract. Using mass spectro- 
metric analysis of the fraction corresponding to the 
95 min peak of the wild type extract, a mass of 1,421 was 
measured, which correlates perfectly with the calculated 
mass of 1,4’21.8 Da for bacitracin A. These results clearly 
1800004 I 
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Figure 5 
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Construction of a bacB gene-disruption 
mutant. (a) An internal 3,897 bp Sad (Sa) 
fragment from the bac6 gene isolated from 
I-BAl was cloned into pBluescipt SK(-). 
(b) The resulting plasmid pBAC-BS was 
linearized with EcoRl (E) and the vector- 
containing portion was ligated with a 
kanamycin-resistance cassette from pDG783 
1521 giving the plasmid pBAC-BAK. (c) This 
plasmid was digested with Sa/l (S), blunted 
and ligated with a blunt-ended DNA fragment 
containing the temperature-sensitive origin of 
replication (REPts) derived from from pLTV1 
[51 I, resulting in the plasmid pBAC-BA. 
(d) The pBAC-BA plasmid was then used to 
transform B. licheniformis ATCC 10716 
protoplasts, which were screened after 
regeneration for kanamycin-resistant colonies. 
(e) Inactivation of REPts by a heat-shift 
treatment to 48°C forced an integrative 
recombination into the chromosomal bad 
gene, which yielded a bacitracin-deficient AK1 
mutant. Abbreviations: P, Pstl; (b), blunt ends; 
Kan’, kanamycin-resistant; Bat+/-, bacitracin 
producing/not producing. 
Figure 6 
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HPLC analysis of butanolic culture broth 
extracts from (a) B. licheniformis ATCC 10716 
and (b) B. licheniformis AK1 . The bacitracin A 
peak and the result of the mass spectroscopy 
analysis of this peak are indicated. 
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indicate that bad is located in the bacitracin-specific Materials and methods 
transcriptional unit. Bacterial strains and growth conditions 
Bacillus licheniformis ATCC 10716 was maintained on agar plates of 
DSM sporulation medium and grown in rich medium (2xYT) at 37°C for 
DNA isolation procedures. Escherichia co/i XL1 Blue (Stratagene, Hei- 
delberg, Germany) was used for preparation of recombinant plasmids. 
E. co/i XL1 Blue MRA(P2) was used as the host for the h-EMBL3 
genomic library and preparations of h-phages. Overexpression of 
recombinant proteins was carried out in E. co/i Ml5 (Giagen, Hilden, 
Germany). For the construction of a gene disruption mutant, derivatives 
of the plasmids pDG783 (521 and pLTVl[51 I were used. Micrococcus 
flaws ATCC 10240 was used as the test strain for microbiological 
bacitracin assays. 
Significance 
This report presents the molecular characterization of the 
bacitracin synthetase genes. Bacitracin is a branched cyc- 
lic dodecylpeptide antibiotic ({Ile-Cys],i,,,~,,-Leu-DGlu- 
Ile-(Lys-D&n-Ile-DPhe-His-DAspAsn),,,,), produced 
in B. licheniformis ATCC 10716 via a nonribosomal 
pathway by a large multienzyme complex which con- 
pounds), such as yersiniabactin and anguibactin [38,39]. 
tains three peptide synthetases, BAl, BA2 and BA3 
[13-151. The genes encoding the three bacitracin synthe- 
These findings, in combination with the fact that baci- 
tases were cloned and sequenced, and were found to be 
organized in an operon. A modular structure typical of 
peptide synthetases [ 181 was detected, within the identified 
tracin also contains a thiazoline ring between its first two 
genes, and the domains identified match the categories of 
amino acids, strongly support the idea that the modified C 
biochemical activity required for bacitracin synthesis. 
BAl is encoded by bucA, the first gene of the identified 
operon, and is thought to activate and incorporate the live 
amino-terminal amino acids into bacitracin ({iso- 
leucine-cysteine),hia,,l;,,- leucine-D-glutamine-isoleucine). 
BAl is comprised of five modules, which include adeny- 
lation (A) and thioesterification (T) modules. These two 
modules are linked by putative condensation (C) 
domains, which are thought to catalyze the transpepti- 
dation of the activated amino acids, thus promoting 
peptide chain growth. Additionally, an internal epimer- 
ization (E) domain was found attached to the fourth 
module. BA2 is encoded by bacB, and is responsible for 
the activation and incorporation of two amino acids 
(lysine-D-ornithine). Two modules and a carboxy-termi- 
nal E domain were identified in BA2. The deduced 
amino-acid specificity of the first two BAl-modules was 
confirmed by cloning, heterologous expression in E. coli 
and ATP-PPi exchange assays with purified AT domain 
proteins. Furthermore, we demonstrated the relevance of 
the cloned genes in bacitracin biosynthesis by construct- 
ing a bacitracin-deficient bacB gene-disruption mutant. 
Like BAl, the bacitracin synthetase BA3 is also respon- 
sible for incorporating five amino acids (isoleucine- 
D-phenylalanine-histidine-D-aspartate-asparagine) into 
bacitracin. The bacC gene encoding BA3 contains live 
modules with two internal E domains in the expected loca- 
tions. Furthermore a putative carboxy-terminal thioest- 
erase domain was detected, as has been reported for other 
bacterial peptide synthetases [ 17,201. Besides these classi- 
cal peptide synthetase domains, a strongly modified C 
domain was found between the first two modules of BAl. 
This domain shares the highest homology (3540%) with 
proteins involved in the biosynthesis of thiazoline-contain- 
ing siderophores (bacterially produced iron-chelating com- 
Transformation of E. coli and DNA manipulations 
Standard genetic techniques for DNA manipulations in vitro, and 
cloning and the transformation of competent E. co/i cells were used 
[53]. Total DNA from 6. licheniformis was obtained using a lysozyme 
treatment and phenol-chloroform extraction 1541. For the construction 
of a I-EMBLS genomic library (Stratagene), chromosomal DNA of 
6. licheniformis ATCC 10716 was partially digested with Sau3Al and 
size-fractionated in 15-40% (w/v) NaCl gradients. Fractions containing 
DNA fragments of 13-22 kb were pooled and ligated to A-EMBL3- 
arms digested with BarnHI. In vitro packaging was performed with 
Gigapack III Gold (Stratagene). For Southern blots and plaque filter 
hybridizations, the ECL random prime-labelling and detection system 
(Amersham/Buchler, Braunschweig, Germany) and positively charged 
nylon membranes (AmershamlBuchler) were used according to the 
manufacturer’s protocol. 
Identification, cloning and sequencing of the bat operon 
For the identification of the bacitracin synthetase genes, a PCR method 
previously described [42] was employed, using degenerate primers 
derived from core sequences 4 and 6 of peptide synthetases [27]. The 
sequences of the degenerate oligonucleotides used were as follows 
(nucleotides in parentheses are degenerate; I, inosine): oligo TGD: 5’- 
T(AT)(CT) CGI ACI GGI GA(TC) (CT)(TG)I G(TG)I CG-3’ and LGG: 
5’-A( GA(GA) (TG)(CG)I CCI CCI (GA)(GA)(GC) I(AC)(AG) 
AA AA-3’. All primers used in this study were synthesized by 
MWG Biotech (Ebersberg, Germany). Variation of the annealing tem- 
perature over a range between 40°C to 60% yielded a set of different 
fragments which were isolated and sequenced. The derived amino-acid 
sequence of PCR fragment 05 (Figure 1 d) showed high homology with 
other peptide synthetases and was used as a probe in the subsequent 
screening of the 6. licheniformis genomic h-EMBLS-library. 
In all, around 8000 plaques were screened with approximately 500 
plaques per agar plate (8.5 cm in diameter), and the phage clone h-BAl 
(Figure 1 d) was isolated. The insert DNA was mapped and subcloned in 
pBluescript SK(-) using the restriction enzymes Sail and EcoRI. 
Sequencing of the double-stranded pBluescript plasmids was per- 
formed with standard universal/SK primers and walking primers derived 
from the determined sequences. Small gaps between the subclones 
were filled by PCR amplification and sequencing of the product or by 
sequencing of the I.-DNA template. In a second round of screening, 
using 5’- and 3’-terminal fragments of the h-BAl-insert as probes, the 
phage clones h-A14.3 and h13.2 were isolated among others. The 
inserts of these phages were also subcloned and sequenced in the 
same way as h-BAl 
Sequencing reactions were carried out using the chain-termination 
method 1551 with dye-labeled dideoxy terminators from the PRISM 
Ready Reaction DyeDeoxy Terminator Cycle Sequencing Kit with 
domain could be responsible for thiazoline ring formation. 
AmpliTaq FS polymerase (Applied Biosystems) according to the manu- 
facturer’s protocol, and analyzed on the ABI 310 genetic analyzer. 
Amplification and cloning of BA 1 AT domains 
PCR amplification of the bacA AT domains (BacAl-AT and 
BacA2-AT) was used to generate the terminal restriction sites for the 
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subsequent cloning and was performed with the Long Range PCR 
System (Boehringer, Mannheim, Germany) following the manufactur- 
er’s protocol. The sequences of the 5’-modified oligonucleotides used 
were as follows (italics, modified sequences; bold, restriction sites): 
oligo 5’-llelAT(Ncol): 5’-TAT/ICC ATG GTT GCT AAA CAT TCA TT- 
3’, 3’-llelAT(Bg/lI): 5’-TAA CAG ATC TGC CAA CCA AAT AAG C-3’, 
5’-Cys2AT(Ncol): 5’.TAT ACC ATG GTT TCA ACC ATC CAA ATG-3’ 
and 3’-Cys2AT(BgIII): 5’-TAA CAG ATC TTT GTT GGG CAG GG-3’. 
The pQE60 Hiss-tag fusion vector (Ciagen) digested with Ncol/Bg/ll 
was used to clone the AT-domain fragments. The fusion sites between 
the vector and insert were confirmed by sequencing with the following 
primers: oligo 5’.promotor: 5’.GGC GTA TCA CGA GGC CC and 3’- 
terminator: 5’-ACG CCC GGC GGC AAC CG-3’. 
Expression, purification and ATP-PP,-exchange of the HisG- 
tagged AT domains 
The pQE60-derivatives containing the amplified AT domains (desig- 
nated pCE-BacBl AT and pQE-BacB2AT; Figure 1 e) were trans- 
formed in E. co/i strain M15(pREP4) and expressed as previously 
described [27], except that cells were induced with 1 mM IPTG at A,,, 
0.7 and allowed to grow for an additional 2 h before harvesting. Purifi- 
cation of the Hi@-tagged proteins (designated BacAl-AT and 
BacA2-AT), was basically carried out as described 1271 using Ni*+- 
affinity chromatography, but cells were broken by three passages 
through a French Press. Expression and purification was checked by 
Coomassie Brilliant Blue-stained SDS-polyacrylamide gels (Figure 3) 
and protein concentration was measured using the Bradford method 
[56]. The amino-acid-dependent ATP-PP,-exchange experiments were 
performed as described previously (271. 
Construction of a bacB gene disruption mutant 
An internal 3,697 bp Sacll DNA fragment of the bacB gene, isolated 
from h-BAl, was cloned in pBluescript SK(-)AE, where the EcoRl 
restriction site had been deleted by digestion with SmallEcoRV, fol- 
lowed by re-ligation of the vector. This plasmid pBAC-BS (Figure 5), 
was digested with EcoRI, the internal fragment BAC-BE (1,368 bp) 
was separated and the fragment containing the vector portion 
(5,469 bp) was ligated with an EcoRI-digested kanamycin-resistance 
cassette (KAN’) from pDG783 [52]. The resulting plasmid pBAC-BAK 
was linearized with Sa/l, blunted and ligated with a blunt cut Psfl/EcoRl 
DNA fragment carrying the temperature-sensitive origin of replication 
(REPts) from pLTV1 [51]. The product plasmid pBAC-BA was trans- 
formed in 6. kheniformis protoplasts as described 1571 with modified 
regeneration conditions according to Gray and Chang [58] and 
kanamycin as selection marker. In order to inactivate the REPts and to 
force integration into the chromosome, the isolated Kanr transformants 
were subjected to a two-stage dilution and heat-shift treatment (48%) 
[59]. Small discs of Whatmann paper (5mm in diameter) were then 
soaked with cultures of heat-stable Kanr colonies and were placed on 
freshly prepared Micrococcus flaws ATCC 10240 test plates [15]. 
After incubation overnight at 37°C bacitracin-deficient (and 
kanamycin-resistant) mutants could be identified by a missing growth- 
inhibition zone of M. flavus. The mutant 8. licheniformis AK1 
(Kan:Bac-) was isolated and the integration of the kanamycin-cassette 
into the chromosomal bacB gene was verified by Southern blots, PCR 
amplification of the chromosomal region corresponding to the bacB 
gene, and sequencing of the PCR product (data not shown). 
Analysis of bacitracin production 
M20 medium (200ml) [60] was inoculated with B. licheniformis and 
incubated with shaking for 30 h at 37’C. The cells were harvested by 
centrifugation and the supernatant was extracted with 2 volumes of 
n-butanol. The organic phase was evaporated to complete dryness and 
resuspended in 50% (v/v) methanol / 0.1 o/, (v/v) trifluoroacetic acid, 
This suspension was analyzed by HPLC for its bacitracin content, 
Reverse-phase HPLC analysis was performed by using a Sephasil TM 
C’s-column (5 urn; 250x4 mm; Pharmacia LKD Biotechnology, 
Freiburg, Germany) and a O-63% (w/v) gradient of acetonitrile / 0.1 O/o 
(v/v) trifluoroacetic acid as mobile phase. Bacitracin was detected by 
absorption at 214 nm and 253 nm. HPLC fractions corresponding to 
absorption peaks were analyzed by mass spectrometry or used in a 
biological assay. For this assay the fractions were evaporated to com- 
plete dryness, resuspended in water and loaded on small discs of 
Whatmann paper (0.5mm in diameter) placed on freshly prepared M. 
flaws test plates [15]. After incubation overnight at 37’C, M. flavus 
growth-inhibition zones were measuredx. 
Mass spectrometric analysis was performed by ‘Abt. f. Gaschro- 
matographie u. Massenspektrometrie, FB Chemie, Phillipps-Universitat 
Marburg. Ionization of samples was performed by electrospray ioniza- 
tion (Hewlett Packard 59987A; ion source: Analytica of Bradford). 
Spectra were recorded using a Hewlett Packard 59898 mass spec- 
trometer. 
Accession numbers 
The nucleotide sequences from 6. licheniformis ATCC 10716 
described in this paper have been submitted to the GenBank database 
under the accession number AF007865 for the region containing the 
peptide synthetases bacA, bacB and bacC. 
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